Skip to main content
. 2021 Jul 5;11:366. doi: 10.1038/s41398-021-01492-7

Fig. 3. Neural molecular substrates of lithium determining its differential affinity and efficacy for BD1 vs BD2.

Fig. 3

Circles represent neural molecular substrates of Li+. Red circles represent the most abundant neural targets of Li+ underlying its therapeutic efficacy in mania (BD1); blue and yellow circles indicate a progressively decreasing number of neural molecular substrates of Li+ in minor and major depressive disorders (cyclothymia and BD2).